NovAliX
PrivateLast Round
Strategic
Aug 7, 2024
Total Funding Raised
$15.3M
Company Overview
NovAliX is a drug discovery company that operates as a contract research organization (CRO) providing services from target identification to the delivery of pre-clinical candidates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovAliX Comps
Public and private peers based on sector, stage, and business model.
NovAliX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 7, 2024 | ||||
| Strategic | Mar 30, 2023 | ||||
| Corporate Funding | Dec 15, 2020 |
NovAliX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Galapagos NV | Strategic |
| Région Grand Est | Corporate Funding |
| Bpifrance | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2025
Monthly visitors increased 64% MoM, reaching 10.5K.
- May 3, 2025
Monthly visitors increased 150% MoM, reaching 7.5K.
NovAliX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NovAliX's valuation, stock price, and market status.
